ULIHF Stock: The United Laboratories International Holdings Limited Stock Price, Analysis & Insights
Get live ULIHF stock price $1.24, comprehensive The United Laboratories International Holdings Limited stock analysis, charts, news, and expert forecast. Real-time ULIHF stock data and investment insights.
Loading chart data...
The United Laboratories International Holdings Limited (ULIHF) Overview
The United Laboratories International Holdings Limited (ULIHF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, ULIHF trades at $1.24 with a market capitalization of 2.45B . Over the past 52 weeks, ULIHF has traded between $1.18 and $2.28 , with the current price positioned at ap...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 2.45B
- Current price: $1.24
- 52-week range: $1.18 - $2.28
- P/E ratio: 7.75
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
The United Laboratories International Holdings Limited functions as a pharmaceutical investment holding company, overseeing the entire spectrum of drug-related activities from initial research and development to manufacturing, distribution, and sales...
Company Information
- CEO
- Hoi Shan Tsoi
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 17000
Contact Information
- Website
- https://www.tul.com.cn
- Address
- 6 Fuk Wang Street
- Country
- HK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 7.8)
✓ Lower volatility stock (Beta: 0.31) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for The United Laboratories International Holdings Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for The United Laboratories International Holdings Limited
- ⚠Investors should consider how The United Laboratories International Holdings Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
2.45B
P/E Ratio (TTM)
7.75
Beta
0.31
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ULIHF with peer companies:
- Price
- $19.59
- Market cap
- 2.77B
- Price
- $9.37
- Market cap
- 4.20B
- Price
- $2.16
- Market cap
- 1.86B
- Price
- $3.98
- Market cap
- 2.80B
- Price
- $5.22
- Market cap
- 6.06B
- Price
- $18.35
- Market cap
- 3.76B
- Price
- $0.47
- Market cap
- 689.04M
- Price
- $1.70
- Market cap
- 1.93B
- Price
- $9.95
- Market cap
- 4.46B
- Price
- $12.22
- Market cap
- 3.93B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.